A drug widely used to treat asthma and allergies may also help fight aggressive cancers, reports a new Northwestern Medicine study that uncovered how tumors hijack common white blood cells to evade immunotherapy.

The findings in mice and human tissues point to a practical, new way to improve treatment for tough tumors, such as triple-negative breast cancer, where immunotherapy often fails.

The study is published in Nature Cancer.